Anika Therapeutics | ANIK - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 171.01B 12.96B 2026-09
Agenus USD 128M 21M 2026-03
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 11.5B 2.72B 2026-06
Enanta Pharmaceuticals USD 122M 98M 2024-12
Halozyme Therapeutics USD 15.62B 3.09B 2026-11
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 24.93B 1.82B 2026-09
Integra LifeSciences USD 1.27B 131M 2026-09
J&J USD 653.61B 42.25B 2026-09
Karyopharm Therapeutics USD 126M 9M 2026-03
Ligand Pharmaceuticals USD 6.23B 108M 2026-09
MacroGenics USD 151M 143M 2026-11
Merit Medical Systems USD 5.15B 1.01B 2026-09
Sanofi EUR 100.56B 13.53B 2026-11
Smith & Nephew USD 12.7B 621.83M 2026-06
Stryker USD 105.63B 15.07B 2026-09
Veracyte USD 4.12B 414M 2026-11
Xencor USD 2.14B 281M 2026-11
Zimmer Biomet Holdings USD 22.63B 5.69B 2026-11